Creoptix launches new WAVEcontrol to deliver automated and label-free analysis for biologics drug-discovery
The WAVEsystem with the WAVEcontrol 4.0 embedded
The WAVEsystem with the WAVEcontrol 4.0 embedded
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Company raises the annual revenue guidance from mid-teens to high teens
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Subscribe To Our Newsletter & Stay Updated